Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000930413-12-002742
Filing Date
2012-05-02
Accepted
2012-05-02 16:16:40
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 c69479_10-q.htm 10-Q 306848
2 c69479_ex31-1.htm EX-31.1 8832
3 c69479_ex31-2.htm EX-31.2 8703
4 c69479_ex32-1.htm EX-32.1 4238
5 c69479_ex32-2.htm EX-32.2 3987
  Complete submission text file 0000930413-12-002742.txt   1981517

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE enzn-20120331.xml EX-101.INS 288067
7 enzn-20120331.xsd EX-101.SCH 17306
8 XBRL CALCULATION FILE enzn-20120331_cal.xml EX-101.CAL 29032
9 XBRL DEFINITION FILE enzn-20120331_def.xml EX-101.DEF 89285
10 XBRL LABEL FILE enzn-20120331_lab.xml EX-101.LAB 110325
11 XBRL PRESENTATION FILE enzn-20120331_pre.xml EX-101.PRE 90959
Mailing Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854
Business Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854 732-980-4500
ENZON PHARMACEUTICALS INC (Filer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-12957 | Film No.: 12805489
SIC: 2836 Biological Products, (No Diagnostic Substances)